| Literature DB >> 28573337 |
Silvia Fallarini1, Alvaro Brittoli1, Michele Fiore2, Grazia Lombardi1, Olivier Renaudet3,4, Barbara Richichi5, Cristina Nativi6.
Abstract
The ability of a rigid α-Tn mimetic (compound 1) to activate murine invariant natural killer T (iNKT) and human natural killer (NK) cells, two subsets of lymphocytes involved in cancer immunesurveillance, was investigated. For this purpose, the mimetic 1 was properly conjugated to a stearic acid containing glycerol-based phospholipid (compound 5) to be presented, in the context of the conserved non polymorphic major histocompatibility complex class I-like molecules (CD1d), to iNKT cells. On the contrary, the mimetic 1 was conjugated to a multivalent peptide-based scaffold (compound 6) to induce NK cell activation.Entities:
Keywords: Glycomimetic; Immunotherapy; Invariant natural killer T cells; Natural killer cells; α-Tn antigen
Mesh:
Substances:
Year: 2017 PMID: 28573337 DOI: 10.1007/s10719-017-9775-6
Source DB: PubMed Journal: Glycoconj J ISSN: 0282-0080 Impact factor: 2.916